Board of Directors

Rebecca is a Managing Director at Deep Track Capital with more than 17 years of experience in the healthcare investment business. Prior she was a Principal at New Leaf Venture Partners, leading crossover and public company strategy. Rebecca has been a board member and observer for several biotechnology companies. Previously, she spent four years on the sell side at both Jefferies and Piper Jaffray, covering biotechnology and specialty pharmaceuticals companies. Rebecca started her career as an investment banking analyst in the Bank of America healthcare group and as a venture capital associate at Bay City Capital. She holds a BS in Biochemistry and Mathematics from Indiana University.